TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
AFT Pharmaceuticals Ltd. ( (AU:AFP) ) has shared an update.
AFT Pharmaceuticals Ltd. has disclosed a change in the shareholding of its Director and Chair, David Flacks. The disclosure indicates that Flacks, through the Waitemata Family Trust, increased his holding of fully-paid ordinary shares in the company from 178,764 to 196,486 shares through on-market purchases. This transaction, involving 17,722 shares at an average price of $2.72 per share, reflects a strategic move by the Director, potentially signaling confidence in the company’s future performance.
More about AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is known for its range of over-the-counter medicines and prescription drugs, catering to both domestic and international markets.
Average Trading Volume: 1,741
Technical Sentiment Signal: Sell
Current Market Cap: A$260.4M
See more insights into AFP stock on TipRanks’ Stock Analysis page.